Circulating angiogenic factors and their association with birth outcomes in preeclampsia (Q43132415)

14 November 2017

title

Circulating angiogenic factors and their association with birth outcomes in preeclampsia (English)

1 reference

14 November 2017

0 references

Asmita V Kulkarni

1

1 reference

14 November 2017

Savita S Mehendale

2

1 reference

14 November 2017

Hemlata R Yadav

3

1 reference

14 November 2017

Anitha S Kilari

4

1 reference

14 November 2017

Vaishali S Taralekar

5

1 reference

14 November 2017

Sadhana R Joshi

6

1 reference

14 November 2017

language of work or name

1 reference

12 March 2010

1 reference

14 November 2017

published in

Hypertension Research

1 reference

14 November 2017

volume

33

1 reference

14 November 2017

issue

6

1 reference

14 November 2017

page(s)

561-567

1 reference

Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

The levels of circulating vascular endothelial growth factor and soluble Flt-1 in pregnancies complicated by preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Angiogenin and vascular endothelial growth factor in pregnancies complicated by preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Circulating angiogenic factors and the risk of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Novel soluble Flt-1 isoforms in plasma and cultured placental explants from normotensive pregnant and preeclamptic women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen--a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Increased sFlt-1 to PlGF ratio in women who subsequently develop preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Placental stress and pre-eclampsia: a revised view.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Preeclampsia: the role of angiogenic factors in its pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Oxidative stress contributes to soluble fms-like tyrosine kinase-1 induced vascular dysfunction in pregnant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Fatty acids, antioxidants, and oxidative stress in pre-eclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Long chain polyunsaturated fatty acids in mothers and term babies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Long-chain polyunsaturated fatty acid composition of breast milk in pre-eclamptic mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Umbilical cord serum vascular endothelial growth factor (VEGF) levels in normal pregnancies and in pregnancies complicated by preterm delivery or pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Excess soluble fms-like tyrosine kinase 1 and low platelet counts in premature neonates of preeclamptic mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

The biology of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Vascular endothelial growth factor: possible role in fetal development and placental function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Multimicronutrient supplementation for undernourished pregnant women and the birth size of their offspring: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Vasoactivity to and endogenous release of vascular endothelial growth factor in the in vitro perfused human placental lobule from pregnancies complicated by preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Vascular endothelial growth factor-mediated induction of manganese superoxide dismutase occurs through redox-dependent regulation of forkhead and IkappaB/NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Long-chain polyunsaturated fatty acids in maternal and infant nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Essential fatty acids in membrane: physical properties and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Fatty acids, inflammation and immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Mechanisms of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Studies of placental vasculogenesis: a way to understand pregnancy pathology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

Circulating angiogenic factors in singleton vs multiple-gestation pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

7 January 2021

Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

7 January 2021

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

7 January 2021

Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

7 January 2021

Angiogenic factors and preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

7 January 2021

Relationships between TGFbeta proteins and oxygen concentrations inside the first trimester human gestational sac

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

7 January 2021

Fatty acids in plasma and red cell membranes in normal humans

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

7 January 2021

Decreased Endothelial Progenitor Cells in Umbilical Cord Blood in Severe Preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

7 January 2021

Altered angiogenesis in preeclampsia: evaluation of a new test system for measuring placental growth factor

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

7 January 2021

Soluble Flt-1 as a diagnostic marker of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

7 January 2021

Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

7 January 2021

The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

7 January 2021

Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

7 January 2021

Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

7 January 2021

A Vascular Endothelial Growth Factor Antagonist Is Produced by the Human Placenta and Released into the Maternal Circulation1

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

7 January 2021

Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

7 January 2021

Concentrations of free vascular endothelial growth factor in the maternal and foetal circulations during pregnancy: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

7 January 2021

Mechanisms of endothelial response to oxidative aggression: protective role of autologous VEGF and induction of VEGFR2 by H2O2

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

7 January 2021

[Polyunsaturated fatty acids: anticonvulsive effects and underlying mechanisms]

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.31

7 January 2021

Identifiers

DOI

10.1038/HR.2010.31

1 reference

14 November 2017

1 reference